- Home
- 应用程序分析
- Pulmonary Disease Board Review
- Pulmonary Disease Board Review Vs. Lung Nodule Tracker
Pulmonary Disease Board Review 对比 Lung Nodule Tracker 的使用情况和统计数据
800 Q&A deliver a rigorous review for pulmonary board certification
Part of the acclaimed McGraw-Hill Education Specialty Board Review series, this well-illustrated review is essential for pulmonary medicine physicians preparing for board certification or recertification. The coverage mirrors the board exam outline of the American Board of Internal Medicine (ABIM), focusing specifically on the most commonly tested topics in obstructive lung disease, critical care, diffuse parenchymal lung disease, sleep medicine, infections, and neoplasms.
Offering more illustrations than similar reviews, Pulmonary Disease Examination and Board Review delivers authoritative coverage of the key concepts tested on the certification exam, including: making a diagnosis, test ordering and interpretation, treatment recommendations, understanding epidemiologic studies, understanding pathophysiology, and applying basic science knowledge to clinical situations.
Features:
• Case-based presentation mirrors the exam format
• Includes numerous high-quality images, including: x-rays, CT scans, and electrocardiograms
• Excellent as clinical refresher in pulmonary medicine
This app is very intuitive and easy to navigate, allowing you to browse the contents or search for topics. The powerful search tool gives you word suggestions that appear in the text as you type, so it is lightning fast and helps with spelling those long medical terms. The search tool also keeps a recent history of past search terms so you can go back to a previous search result very easily. You can also change the text size for easier reading. Bookmark cases, add notes, answer multiple choice questions, view your statistics, and create customized tests on your way to mastering the content.
After the app has been downloaded, no internet connection is needed to retrieve the content of the app. All of the text and images are available to you on your device anytime, anywhere, and lightning fast. This app is also automatically optimized for whatever size device you are currently using, either phone or tablet.
Check out https://usatinemedia.com to learn more and watch a video demo of this app.
This interactive app contains the full content of Pulmonary Disease Examination and Board Review by McGraw-Hill Education.
ISBN-13: 978-0071845298
ISBN-10: 0071845291
Editor:
Ronaldo Collo Go, MD
Faculty
Division of Pulmonary, Critical Care, and Sleep Medicine
Mount Sinai Beth Israel
New York, New York
and
Crystal Run Health Care
Middletown, New York
Disclaimer: This app is intended for the education of healthcare professionals and not as a diagnostic and treatment reference for the general population.
Developed by Usatine Media
Richard P. Usatine, MD, Co-President, Professor of Family & Community Medicine, Professor of Dermatology and Cutaneous Surgery, University of Texas Health San Antonio
Peter Erickson, Co-President, Lead Software Developer
- Apple 应用商店
- 付费
- 医疗
商店排名
- -
Lung Nodule Tracker is a powerful application designed to monitor the development of cancerous lung nodules in patients. With its comprehensive features, healthcare professionals can efficiently schedule follow-up scans, track patient progress, and assign RADS scores to nodules. The app goes beyond by automating the patient experience through scheduled emails and text reminders, ensuring that important appointments are not missed. By leveraging Lung Nodule Tracker, healthcare providers can streamline their workflow and enhance patient care in the ongoing management of lung nodules.
- Apple 应用商店
- 免费
- 医疗
商店排名
- -
Pulmonary Disease Board Review与Lung Nodule Tracker排名比较
对比 Pulmonary Disease Board Review 与 Lung Nodule Tracker 在过去 28 天内的排名趋势
排名
没有可用的数据
Pulmonary Disease Board Review 对比 Lung Nodule Tracker 的排名,按国家/地区比较
对比 Pulmonary Disease Board Review 与 Lung Nodule Tracker 在过去 28 天内的排名趋势
无数据可显示
通过免费试用版比较任何网站
Pulmonary Disease Board Review VS.
Lung Nodule Tracker
十二月 15, 2024